The best history!Tuberculosis of Jinyintan Hospital entered the top ten nationwide

Wuhan Evening News August 10th (Reporter Zhang Jian Correspondent Lin Kun) Recently, the Chinese Academy of Medical Sciences released the ranking of science and technology quantity (STEM) of the Chinese Hospital/Chinese Medical College in 2021. The tuberculosis disease in Wuhan Jinshan Tan Hospital entered the top ten in the ranking of Chinese hospitals, and it jumped from 28th last year to 10th place. The 25th, 40th, and 49th place in the list of infectious diseases, respiratory diseases, and thoracic science science list, all the highest level of history.

At the same time, in the five -year total scientific and technological value ranking, the tuberculosis disease in Jin Yintan Hospital in Wuhan City ranked 11th in the country, ranking the top of Hubei.

It is understood that the "Chinese Hospital's STEM ranking" research object covers 1641 hospitals across the country, including 1,220 three -level hospitals and 421 other three -level hospitals. The scientific and technological quantitative calculation index system fully reflects the actual value of clinical research, attaches importance to patent and patent transformation, strengthens scientific research integrity, and builds an institutional standard system. The level of science and technology comprehensive strength.

Wuhan Jinyan Tan Hospital is a chairman of the Hubei Medical Association's Tuberculosis Branch. It has outstanding clinical treatment and scientific research and innovation strength in terms of tuberculosis. +Medical and Defense Cooperation+Patient Care "Trinity Tuberculosis Prevention" Jinyin Lake Model ". In particular, the successful treatment rate of dystocia and complex drug -resistant tuberculosis was nearly 70%. The latest short -range planning success rate can reach 83.3%, which is at a leading level in China.

In 2021, the high score of the high score of the major new drugs led by the hospital created a major national science and technology special special specialized in the national science and technology major special projects, the construction of the high score of the new drug clinical evaluation technology platform, and the relevant results were simultaneously appeared in the national "13th Five -Year Plan" scientific and technological innovation achievement exhibition.

[Edit: Yu Lina]

- END -